X
Xin Wang
Researcher at Peking University
Publications - 1043
Citations - 30114
Xin Wang is an academic researcher from Peking University. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 59, co-authored 762 publications receiving 22731 citations. Previous affiliations of Xin Wang include Beihang University & Sichuan University.
Papers
More filters
Journal ArticleDOI
Exploring the Binding Mechanism of a Supramolecular Tweezer CLR01 to 14-3-3σ Protein via Well-Tempered Metadynamics
TL;DR: The proposed computational strategies can be extended to understand the binding mechanism of multi-binding sites proteins with supramolecules and will, thus, be useful toward drug design.
Journal ArticleDOI
Clinical significance of serum antinuclear antibodies in patients with autoimmune hepatitis and comorbidity.
TL;DR: Wang et al. as discussed by the authors compared the clinical features of AIH with immune diseases, including clinical characteristics, prognosis and outcome, and aimed to systematically assess clinical characteristics and prognosis in autoimmune hepatitis accompanied by immune diseases.
Journal ArticleDOI
Effects of Peroral Microbiota Transplantation on the Establishment of Intestinal Microorganisms in a Newly-Hatched Chick Model
TL;DR: In this paper , a study was carried out to compare gut microbial community composition, diversity, and function with and without microbiota transplantation in a newly-hatched chick model, and the results showed that Aestuariispira, Christensenella, Fervidicella, Gracilibacter, Haloferula, Mycoplasma, Novispirillum, and Pantoea were more abundant (p < 0.05) in the transplantation group than those in the control group.
Journal ArticleDOI
Discovery of novel aminosaccharide-based sulfonamide derivatives as potential carbonic anhydrase II inhibitors.
Xin Wang,Yan-lian Feng,Xiao-yu Zhao,Ran An,Chun Cao,Meng-bi Guo,Rui Zhang,Yuanxin Wang,Zhuang Hou,Chun Guo +9 more
TL;DR: In this paper, a new class of novel sulfonamides incorporating aminosaccharide tails were designed and synthesized based on the sugar-tail approach, and all the novel compounds were evaluated for their inhibitory activities against three carbonic anhydrase (CA, EC 4.2.1) isoenzymes (hCA I, hCA II and hCA IX).